Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Gonadotropin-Releasing Hormone and Progestins

Research Papers that Mention the Interaction

Progestogens should be used before LHRH agonists or estrogens.
Clinical therapeutics  •  2009  |  View Paper
These binding sites mediate the inhibitory effects of GnRH and its agonists on gonadotropin-stimulated estrogen, progestin and androgen biosynthesis.
Journal of steroid biochemistry  •  1985  |  View Paper
Evidence on harms was scanty, but GnRH analogues, danazol and depot progestagens were associated with higher rates than other interventions.
The Cochrane database of systematic reviews  •  2014  |  View Paper
Several clinical trials demonstrate that progestins inhibit and/or reverse the ability of hypoestrogenism induced by a gonadotropin-releasing hormone agonist to shrink uterine myomas, suggesting a critical role for progesterone in growth of myomas.
American journal of obstetrics and gynecology  •  1995  |  View Paper
Bone loss with gonadotropin-releasing hormone agonists could be prevented or attenuated with progestins , and this is worthy of further studies.
American journal of obstetrics and gynecology  •  1993  |  View Paper
Although gonadotropin-releasing hormone agonists are associated with hypoestrogenic side effects, such as hot flashes and reversible bone density loss, recent studies suggest that the risk of these side effects may be modified when gonadotropin-releasing hormone agonists are combined with a progestin.
American journal of obstetrics and gynecology  •  1992  |  View Paper
Nevertheless, a short-term study of patients with endometriosis showed that adding small amounts of progestin during treatment with a gonadotropin-releasing hormone agonist may help prevent bone changes.
American journal of obstetrics and gynecology  •  1990  |  View Paper
In conclusion, intermittent administration of appropriate LH-RH agonist dosing in combination with a progestogen would effectively block ovulation while preserving adequate cyclic estradiol secretion and could be an alternative contraceptive approach.
Fertility and sterility  •  1985  |  View Paper
It was found that the EE-induced augmentation of pituitary responsiveness to GnRH is diminished by the addition of progestins.
Contraception  •  1985  |  View Paper
Conversely, concurrent progestin stimulation potentiated the E2-induced augmentation of tissue concentrations of GnRH receptor.
These data indicate that prolonged progestin stimulation leads to a decrease in tissue concentrations of GnRH receptor and GnRH receptor mRNA.
The Journal of endocrinology  •  1997  |  View Paper
Show More